01066.HK
Shandong Weigao Group Medical Polymer Company Limited
HKSE · Healthcare · Medical - Instruments & Supplies · CN
HKD 3.23
−2.42%Oct 21, 2026, 09:17 UTC
Shandong Weigao Group Medical Polymer Co. Ltd. repurchased 380,000 shares at HK$3.17–HK$3.24 per share for approximately HK$1.2174 million.
Source:Oct 8, 2026, 00:24 UTC
Shandong Weigao Group Medical Polymer Co. Ltd. repurchased 143,200 of its shares for approximately HK$463,700 at HK$3.225–HK$3.25 per share.
Source:Sep 24, 2026, 10:15 UTC
Weigao Blood Purification completed the registration of 277 million new shares issued at 30.72 yuan per share to acquire 100% of Weigao Purui from Weigao Group, Weihai Shengxi and Weihai Ruiming, raising total share capital to 695 million shares and making Weigao Group the controlling shareholder.
Source:Sep 24, 2026, 08:06 UTC
Chutian Huatong and Weigao Group held a special product exchange meeting on thermal compression distilled water machines in China on September 21, 2026, discussing pharmaceutical water preparation technology, equipment upgrades, and cost reduction.
Source:Sep 16, 2026, 00:38 UTC
Shandong Weigao repurchased 160,400 of its own shares on September 15 at prices between HK$3.135 and HK$3.18, for about HK$507,600.
Source:Aug 25, 2026, 09:06 UTC
Weigao Group declared an interim dividend of RMB 0.0854 per share for the six months ended June 2026, compared with RMB 0.0969 per share in the prior year period.
Source:Aug 25, 2026, 09:06 UTC
Weigao Group reported interim results for the six months ended June 2026, with net profit of RMB 774 million, down 23.2% year-on-year, and revenue of RMB 6.849 billion, up 3.1% year-on-year.
Source:Aug 23, 2026, 06:15 UTC
Shandong Weigao Medical Polymer is scheduled to report its quarterly earnings after market close on Tuesday, August 25th.
Source: